All In MedTech

Device Trial Radar · NCT06817733

Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Apr 15, 2025

Primary completion

Dec 30, 2026

Study completion Jun 30, 2027

Sponsor

Lead sponsor
Chinese PLA General HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 10, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 45 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates a new imaging-guided approach for treating benign prostatic hyperplasia (BPH), also known as enlarged prostate. BPH is a common condition in older men that can cause bothersome urinary symptoms. Water vapor thermal therapy (Rezūm) is an FDA-approved and NMPA-approved treatment that uses steam to shrink the enlarged prostate. Traditionally, this procedure is performed using ultrasound guidance alone. This study uses an advanced imaging technique that combines MRI (magnetic resonance imaging) with real-time ultrasound and electromagnetic navigation. This combination allows doctors to see the prostate more clearly and deliver the steam treatment more precisely to the areas that need it. The study will examine: * Whether this imaging-guided approach can effectively reduce prostate size and improve urinary symptoms * How safe this treatment method is * Whether the advanced imaging helps target the treatment more accurately Participants will undergo the steam treatment procedure and will be followed for 6 months with regular check-ups, questionnaires about their urinary symptoms, and imaging tests to measure changes in prostate size.

Conditions

  • Benign Prostatic Hyperplasia (BPH)

Interventions

  • Procedure/Surgery: MRI/TRUS Fusion-Guided Transurethral Water Vapor Thermal TherapyProcedure

    After anesthesia, the patient is placed in the lithotomy position, and standard aseptic preparation and draping are performed. A cystoscope and a transrectal ultrasound (TRUS) probe are inserted. Following real-time image fusion and localization according to the preoperative plan, needles are inserted to deliver thermal vaporization to the prostate.Each needle deployment delivers steam for 9 seconds, and multiple injections are performed to achieve comprehensive coverage of the hyperplastic tissue. The entire treatment is typically completed within 3-5 minutes after the first needle insertion.

  • Rezūm Water Vapor Thermal Therapy System with MRI/TRUS Fusion and Electromagnetic NavigationDevice

    The Rezūm System is an FDA-cleared and NMPA-approved transurethral water vapor thermal therapy device for the treatment of benign prostatic hyperplasia (BPH). The system delivers thermal energy in the form of water vapor to ablate hyperplastic prostate tissue. In this study, the Rezūm treatment is performed using an integrated image guidance platform that combines: 1. Preoperative multiparametric MRI for detailed visualization and treatment planning 2. Real-time transrectal ultrasound (TRUS) for intraoperative imaging 3. Electromagnetic navigation technology for real-time tracking of instrument position 4. Image fusion software that registers and merges preoperative MRI with intraoperative TRUS images This integrated approach enables precise targeting of hyperplastic tissue, accurate needle placement, and optimal distribution of thermal energy throughout the treatment zone.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Volume changes in the prostate transition zoneTime frame: From enrollment to 6 months after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chinese PLA General Hospital

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.